IMST-22. THERAPEUTIC TARGETING OF THE Wnt-β-CATENIN PATHWAY ALLEVIATES GLIOMA-INDUCED IMMUNOSUPPRESSION AND CAUSES INHIBITION OF GLIOMA PROGRESSION
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.